Vytorin, Zetia prescriptions rise in December

Thursday, January 22nd, 2009

Schering-Plough Corp said on Tuesday that U.S. prescriptions for the cholesterol drugs it sells with Merck & Co rose 8.7 percent in December, reclaiming most of the ground lost in November. The U.S. drugmaker, in a regulatory filing, said combined prescriptions for Vytorin and Zetia climbed back over the 2 million mark in December to about 2.15 […]